Analyst DowngradeAnalyst downgrades ALIM shares to Hold, from Buy, and removes the prior 12-month price target.
Rating DowngradeGiven the price of ALIM shares after the announcement, the rating for ALIM has been downgraded to Neutral from Buy.
Revenue ContingencyPayments of CVR are contingent upon the achievement of $140M in net revenue on sales of ILUVIEN and YUTIQ for 2026.